20 Oct 2009: The Pharmaceutical Roundtable is a partnership between the ACS Green Chemistry Institute® and leading global pharmaceutical-related companies. The roundtable was founded in 2005 to promote innovation while catalysing the integration of green chemistry and green engineering in the pharmaceutical industry. Dr. Reddy’s is one of the world’s first generic pharmaceutical companies to join the Roundtable as an associate member.

Over the years, process conditions, economics, ever-increasing environmental controls and social pressure have induced the need to incorporate Green Chemistry principles into the synthesis of Active Pharmaceutical Ingredients (APIs) and Intermediates. As an associate member of the ACS GCI Pharmaceutical Roundtable, Dr. Reddy’s will further intensify efforts to make the processes green. In-house incorporation of green principles into synthetic route design will bring synergy among environment, chemistry and economy.

Commenting on the development, GV Prasad, Vice-Chairman and CEO, Dr. Reddy’s said, “We are privileged to be part of this initiative. At Dr. Reddy’s we believe that Green chemistry can play a major role in improving our environmental performance and contribute towards sustainable operations while actually improving our competitiveness. We look forward to collaborating with the scientific community in creating awareness and educating the future generation of scientists worldwide for a sustainable planet.”